- /
- Supported exchanges
- / US
- / LMAT.NASDAQ
LeMaitre Vascular Inc (LMAT NASDAQ) stock market data APIs
LeMaitre Vascular Inc Financial Data Overview
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It also provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular and porcine patches; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with LeMaitre Vascular Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LeMaitre Vascular Inc data using free add-ons & libraries
Get LeMaitre Vascular Inc Fundamental Data
LeMaitre Vascular Inc Fundamental data includes:
- Net Revenue: 241 M
- EBITDA: 72 225 K
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: 0.57
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LeMaitre Vascular Inc News
New
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve
For Immediate Release Chicago, IL – December 2, 2025 – Stocks in this week’s article are Life Time Group Holdings, Inc. LTH, Cardinal Health, Inc. CAH, LeMaitre Vascular, Inc. LMAT and Flowserv...
4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026
An ill-informed investor can easily lose money by betting on a stock solely based on the numbers flashing across a real-time screen. As we move toward 2026, this risk becomes even more pronounced, wit...
Is LeMaitre Vascular’s Drop an Opportunity After Expansion and Regulatory News?
Curious if LeMaitre Vascular is a bargain buy, a hidden gem, or just treading water? Let's peel back the layers and see if the stock's true value stands out in today's market. After a strong three- an...
LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness
LeMaitre Vascular (LMAT) has captured investor attention recently, sparking conversations about what might be driving its stock moves. With its portfolio of vascular devices and presence across global...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.